Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 3090-3095, July 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harris, P. E.
Right arrow Articles by Moore, M. A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, P. E.
Right arrow Articles by Moore, M. A. S.

Distinct Differentiation-inducing Activities of {gamma}-Interferon and Cytokine Factors Acting on the Human Promyelocytic Leukemia Cell Line HL-601

Paul E. Harris2, Peter Ralph3, Janice Gabrilove, Karl Welte, Rashida Karmali4 and Malcolm A. S. Moore

Cornell University Medical College, Sloan-Kettering Division and the Laboratory of Developmental Hematopolesis, Memorial Sloan-Kettering Cancer Center, New York New York 10021

The human promyelocytic leukemia cell line HL-60 and monoblastic leukemia cell line U937 undergo differentiation when induced by lymphokine and cytokine preparations. Growth inhibition, acquisition of immunoglobulin Fc receptors, increased expression of monocyte-related surface antigens, and an increase in lysosomal enzyme contents accompany maturation induced by {gamma}-interferon and other cytokine factors tested. Additionally, increased receptors for chemotactic peptide (fMLPR), increased hydrogen peroxide release in response to phorbol myristic acetate stimulation, and the release of prostaglandins (PGE2 and 6-keto-PGF1a) follow exposure to lymphokine and cell line sources of myeloid colony-stimulating activity (CSA). {gamma}-Interferon ({gamma}-IFN) induced fMLPR in HL-60 (only at 1000 units/ml) but not in U937. Additionally, {gamma}-IFN did not induce prostaglandin release in either cell line. These myeloid colony-stimulating activity-associated differentiation-inducing factors were obtained from the human heptoma cell line SK-Hep and bladder carcinoma cell line 5637, which were free of interferon activity. The 2-day phytohemagglutinin-induced lymphokine contained no detectable CSA and was a good source of differentiation activity. A simple, rapid assay for a new human CSA with pluripotent hematopoietic stimulating activity (pluripoietin) is described based on stimulation of [3H]glucosamine incorporation. Cell line conditioned media containing pluripoietin, purified pluripoietin, and {gamma}-IFN are active in this assay. These myeloid leukemia cell line differentiation factors are thus different from interferon and conventional CSA. These results suggest that endogenous human cytokines may have a role in the differentiation of leukemic as well as normal myeloid cells.

1 This work was supported by the American Cancer Society Grant CH-3F, NIH Grants CA 33484, CA 32516, HL 31780, and K08 CA00966, and the Gar Riechman Foundation.

2 To whom requests for reprints should be addressed, at Dept. of Developmental Hematopolesis, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.

3 Current address: Cetus Corporation, 1400 E. 53rd St., Emeryville, CA 94603.

4 Current address: Department of Nutrition, Cook College, P.O. Box 231, Rutgers University, New Brunswick, NJ 08903.

Received 1/ 8/85. Revised 4/ 3/85. Accepted 4/ 5/85.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
H. Hovhannisyan, B. Cho, P. Mitra, M. Montecino, G. S. Stein, A. J. van Wijnen, and J. L. Stein
Maintenance of Open Chromatin and Selective Genomic Occupancy at the Cell Cycle-Regulated Histone H4 Promoter during Differentiation of HL-60 Promyelocytic Leukemia Cells
Mol. Cell. Biol., February 15, 2003; 23(4): 1460 - 1469.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. T. Kyono, R. de Jong, R. Kil Park, Y. Liu, N. Heisterkamp, J. Groffen, and D. L. Durden
Differential Interaction of Crkl with Cbl or C3G, Hef-1, and {gamma} Subunit Immunoreceptor Tyrosine-Based Activation Motif in Signaling of Myeloid High Affinity Fc Receptor for IgG (Fc{gamma}RI)
J. Immunol., November 15, 1998; 161(10): 5555 - 5563.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.